These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 19162108)
1. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Tekiel V; Alba-Soto CD; González Cappa SM; Postan M; Sánchez DO Vaccine; 2009 Feb; 27(9):1323-32. PubMed ID: 19162108 [TBL] [Abstract][Full Text] [Related]
2. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768 [TBL] [Abstract][Full Text] [Related]
3. Identification of Eimeria tenella genes encoding for secretory proteins and evaluation of candidates by DNA immunisation studies in chickens. Klotz C; Gehre F; Lucius R; Pogonka T Vaccine; 2007 Sep; 25(36):6625-34. PubMed ID: 17675183 [TBL] [Abstract][Full Text] [Related]
12. [Exoantigens of Trypanosoma cruzi. Epitopes reactive against immunoglobulins of patients with Chagas' disease]. Gruppi A; Moretti ER; Basso B; Vottero-Cima E Medicina (B Aires); 1988; 48(2):161-6. PubMed ID: 3148093 [No Abstract] [Full Text] [Related]
13. Field evaluation of four novel enzyme immunoassays for Chagas' disease in Venezuela blood banks: comparison of assays using fixed-epimastigotes, fixed-trypomastigotes or trypomastigote excreted-secreted antigens from two Trypanosoma cruzi strains. Berrizbeitia M; Ndao M; Bubis J; Gottschalk M; Aché A; Lacouture S; Medina M; Ward BJ Transfus Med; 2006 Dec; 16(6):419-31. PubMed ID: 17163873 [TBL] [Abstract][Full Text] [Related]
14. Immunization against Trypanosoma cruzi using killed antigens and with saponin as adjuvant. Neal RA; Johnson P Acta Trop; 1977 Mar; 34(1):87-96. PubMed ID: 16471 [TBL] [Abstract][Full Text] [Related]
15. Biolistic DNA vaccination against Trypanosoma infection. Bryan M; Guyach S; Norris KA Methods Mol Biol; 2013; 940():305-15. PubMed ID: 23104351 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection. García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305 [TBL] [Abstract][Full Text] [Related]
17. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era. Dumonteil E Infect Genet Evol; 2009 Dec; 9(6):1075-82. PubMed ID: 19805015 [TBL] [Abstract][Full Text] [Related]
18. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice. Bhatia V; Garg NJ Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728 [TBL] [Abstract][Full Text] [Related]
19. Cloning of a partial length cDNA encoding the C-terminal portion of the 75-77-kDa antigen of Trypanosoma cruzi. Yang S; Bergman LW; Scholl DR; Rowland EC J Eukaryot Microbiol; 1994; 41(5):435-41. PubMed ID: 7804242 [TBL] [Abstract][Full Text] [Related]
20. [Molecular and immunologic bases for the development of a vaccine against Chagas disease]. Segura EL; Cardoni RL; Búa J; Rottenberg ME; Bontempi EJ; Esteva MI; Carlomagno MA; De Titto EH; Ruiz AM Medicina (B Aires); 1989; 49(3):203-9. PubMed ID: 2518642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]